- Home
- APLS vs DXC Comparison
APLS vs DXC Comparison
Compare APLS & DXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- DXC
- Stock Information
- Founded
- APLS 2009
- DXC 1959
- Country
- APLS United States
- DXC United States
- Employees
- APLS N/A
- DXC N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- DXC EDP Services
- Sector
- APLS Health Care
- DXC Technology
- Exchange
- APLS Nasdaq
- DXC Nasdaq
- Market Cap
- APLS 2.2B
- DXC 2.9B
- IPO Year
- APLS 2017
- DXC N/A
- Fundamental
- Price
- APLS $16.93
- DXC $15.20
- Analyst Decision
- APLS Buy
- DXC Hold
- Analyst Count
- APLS 19
- DXC 6
- Target Price
- APLS $37.50
- DXC $17.00
- AVG Volume (30 Days)
- APLS 2.9M
- DXC 1.9M
- Earning Date
- APLS 05-07-2025
- DXC 05-14-2025
- Dividend Yield
- APLS N/A
- DXC N/A
- EPS Growth
- APLS N/A
- DXC 356.52
- EPS
- APLS N/A
- DXC 2.10
- Revenue
- APLS $775,839,000.00
- DXC $12,871,000,000.00
- Revenue This Year
- APLS $1.54
- DXC N/A
- Revenue Next Year
- APLS $22.80
- DXC N/A
- P/E Ratio
- APLS N/A
- DXC $7.24
- Revenue Growth
- APLS 48.04
- DXC N/A
- 52 Week Low
- APLS $16.10
- DXC $13.44
- 52 Week High
- APLS $43.76
- DXC $24.83
- Technical
- Relative Strength Index (RSI)
- APLS 41.44
- DXC 46.56
- Support Level
- APLS $16.61
- DXC $14.61
- Resistance Level
- APLS $17.48
- DXC $15.55
- Average True Range (ATR)
- APLS 0.86
- DXC 0.72
- MACD
- APLS 0.09
- DXC -0.03
- Stochastic Oscillator
- APLS 28.47
- DXC 39.05
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About DXC DXC Technology Company
DXC Technology Co is a vendor-independent IT services provider. The company's operating segment includes Global Business Services (GBS) and Global Infrastructure Services (GIS). It generates maximum revenue from the GIS segment. GIS offerings include Cloud and Security; IT Outsourcing and Modern Workplace. Geographically, it derives a majority of revenue from the Other Europe region.